The increasing challenge of genetic counseling for cystic fibrosis. 2019

Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, 29425, United States. Electronic address: foilk@musc.edu.

Genetic counseling for cystic fibrosis (CF) is challenged by intricate molecular mechanisms, complex phenotypes, and psychosocial needs. CFTR variant interpretation has become critical; this manuscript examines variant nomenclature and classes, as well as opportunities and challenges posed by genetic technologies and genotype-directed therapies. With post-graduate training in medical genetics and counseling, genetic counselors educate patients and families, facilitate testing and interpretation, and help integrate genetic information into diagnosis and treatment. They support families, ranging from carrier couples or new parents, to children understanding their disease, to adults with CF contemplating reproduction. The changing face of CF increasingly highlights the critical importance of genetic information to patients and their families. Genetic counselors are uniquely poised to translate this information in diagnostics and personalized care. Genetic counselors straddle molecular and clinical realms, helping patients adapt, plan, and gain access to appropriate therapies.

UI MeSH Term Description Entries
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005817 Genetic Counseling An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered. Counseling, Genetic,Genetic Counseling, Prenatal,Prenatal Genetic Counseling
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D057285 Precision Medicine Clinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile. Individualized Medicine,Predictive Medicine,P Health,P-Health,Personalized Medicine,Theranostics,Medicine, Individualized,Medicine, Personalized,Medicine, Precision,Medicine, Predictive,Theranostic
D018579 Patient Selection Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols. Patient Recruitment,Research Subject Recruitment,Selection Criteria,Research Subject Selection,Selection for Treatment,Selection of Research Volunteers,Selection of Subjects,Criteria, Selection,Recruitment, Patient,Recruitment, Research Subject,Recruitments, Research Subject,Research Subject Recruitments,Research Subject Selections,Research Volunteers Selection,Research Volunteers Selections,Selection for Treatments,Selection, Patient,Selection, Research Subject,Selections, Research Subject,Subject Recruitment, Research,Subject Recruitments, Research,Subject Selection, Research,Subject Selections, Research,Subjects Selection,Subjects Selections,Treatment, Selection for,Treatments, Selection for,Volunteers Selection, Research
D019005 Cystic Fibrosis Transmembrane Conductance Regulator A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. (Hum Genet 1994;93(4):364-8) CFTR Protein,Chloride channels, ATP-gated CFTR,Chloride channels, ATP gated CFTR,Protein, CFTR

Related Publications

Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
August 2000, Revue des maladies respiratoires,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
December 1973, American family physician,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
April 1978, Monatsschrift fur Kinderheilkunde,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
March 1989, American journal of human genetics,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
May 1991, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
November 1979, American journal of obstetrics and gynecology,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
January 1989, Acta paediatrica Scandinavica. Supplement,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
January 1992, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
October 1987, Clinical genetics,
Kimberly E Foil, and Amy Powers, and Karen S Raraigh, and Kimberly Wallis, and Kevin W Southern, and Danieli Salinas
January 1990, Birth defects original article series,
Copied contents to your clipboard!